Intestinal secretory and absorptive function in Trichinella spiralis mouse model of postinfective gut dysfunction: Role of bile acids

Gut

Volumn 57, Issue 1, 2008, Pages 41-48

  Kalia, N ^a,d   Hardcastle, J ^a   Keating, C ^a   Pelegrin, P ^a   Grundy, D ^a   Grasa, L ^b   Bardhan, K D ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APICAL SODIUM DEPENDENT BILE ACID TRANSPORTER; BILE ACID; TAUROCHOLIC ACID; TAURODEOXYCHOLIC ACID; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE ACID MALABSORPTION; CONTROLLED STUDY; DIARRHEA; ENTERITIS; IMMUNOHISTOCHEMISTRY; INTESTINAL DYSMOTILITY; INTESTINE ABSORPTION; INTESTINE SECRETION; MALABSORPTION; MOUSE; NONHUMAN; POSTINFECTIVE GUT DYSFUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT CIRCUIT CURRENT; TRICHINELLA SPIRALIS; WESTERN BLOTTING;

ANIMALS; BILE ACIDS AND SALTS; GASTROINTESTINAL MOTILITY; INTESTINAL ABSORPTION; IRRITABLE BOWEL SYNDROME; MICE; MODELS, ANIMAL; TRICHINELLA SPIRALIS; TRICHINOSIS;

EID: 38349190683     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.118356     Document Type: Article

References (37)

1. Spiller RC. Irritable bowel syndrome. Br Med Bull 2005;72:15-29.
2. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45:II43-7.
3. Crowell MD, Harris L, Jones MP, et al. New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments. Curr Gastroenterol Rep 2005;7:272-9.
4. Talley NJ. Environmental versus genetic risk factors for irritable bowel syndrome: clinical and therapeutic implications. Rev Gastroenterol Disord 2005;5:82-8.
5. Gershon MD. Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome. J Clin Gastroenterol 2005;39:S184-93.
6. Barbara G, De Giorgio R, Stanghellini V, et al. New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther 2004;20:1-9.
7. Parry S, Forgacs I. Intestinal infection and irritable bowel syndrome. Eur J Gastroenterol Hepatol 2005;17:5-9.
8. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003;124:1662-71.
9. Akiho H, Deng Y, Blennerhassett P, et al. Mechanisms underlying the maintenance of muscle hypercontractility in a model of post-infective gut dysfunction. Gastroenterology 2005;129:131-41.
10. Barbara G, Vallance BA, Collins SM. Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology 1997;113:1224-32.
11. Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003;98:1578-83.
12. Wildt S, Norby Rasmussen S, Lysgard Madsen J, et al. Bile acid malabsorption in patients with chronic diarrhoea: clinical value of SeHCAT test. Scand J Gastroenterol 2003;38:826-30.
13. Smith MJ, Cherian P, Raju GS, et al. Bile acid malabsorption in persistent diarrhoea. J R Coll Physicians Lond 2000;34:448-51.
14. Hofmann AF. Bile secretion and the enterohepatic circulation of bile acids. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Sleisenger & Fordtran's gastrointestinal and liver disease, 6th edn. Philadelphia: W B Saunders Company, 1998;937-948.
15. Dawson PA, Haywood J, Craddock AL, et al. Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice. J Biol Chem 2003;278:33920-7.
16. Barrett KE, Keely SJ. Chloride secretion by the intestinal epithelium:molecular basis and regulatory aspects. Ann Rev Physiol 2000;62:535-72.
17. Oddsson E, Rask-Madsen J, Krag E. A secretory epithelium of the small intestine with increased sensitivity to bile acids in irritable bowel syndrome associated with diarrhoea. Scand J Gastroenterol 1978;13:408-16.
18. Hardcastle J, Hardcastle PT, Chapman J, et al. Taurocholic acid-induced secretion in normal and cystic fibrosis mouse ileum. J Pharm Pharmacol 2001;53:711-19.
19. Hardcastle J, Hardcastle PT, Chapman J, et al. Ursodeoxycholic acid action on the transport function of the small intestine in normal and cystic fibrosis mice. J Pharm Pharmacol 2001;53:1457- 67.
20. Hardcastle J, Harwood MD, Taylor CJ. Absorption of taurocholic acid by the ileum of normal and transgenic ΔF508 cvstic fibrosis mice. J Pharm Pharmacol 2004;56:445-52.
21. Gelbmann CM, Schteingart CD, Thompson SM, et al. Mast cells and histamine contribute to bile acid-stimulated secretion in the mouse colon. J Clin Invest 1995;95:2831-9.
22. Bercik P, Wang L, Verdu EF, et al. Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. Gastroenterol 2004;127:179-87.
23. Castro GA, Fairburn D. Carbohydrates and lipids in Trichinella spiralis larvae and their utilisation in vitro. J Parasitol 1969;55:51-8.
24. Andres H, Rock R, Bridges RJ, et al. Submucosal plexus and electrolyte transport across rat colonic mucosa. J Physiol 1985;364:301-12.
25. Cachefo A, Boucher P, Dusserre E, et al. Stimulation of cholesterol synthesis and hepatic lipogenesis in patients with severe malabsorption. J Lipid Res 2003;44:1349-54.
26. Hofmann AF. Bile acids - the good, the bad and the ugly. News in Physiol Scie 1999;14:24-9.
27. Stelzner M, Hoagland V, Somasundaram S. Distribution of bile acid absorption and bile acid transporter gene message in the hamster ileum. Eur J Physiol 2000;440:157-62.
28. Jund D, Fantin AC, Scheurer U, et al. Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor. Gut 2004;53:78-84.
29. Chen F, Ma L, Sartor RB, et al. Inflammatory-mediated repression of the rat ileal sodium-dependent bile acid transporter by c-fos nuclear translocation. Gastroenterol 2002;123:2005-16.
30. Trauner M, Boyer JL. Bile salt transporters: molecular characterisation, function and regulation. Physiol Rev 2003;83:633-71.
31. Wheatcroft J, Wakelin D, Smith A, et al. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of post-infectious bowel dysfunction. Neurogastroenterol Motil 2005;17:863-70.
32. Dunlop SP, Jenkins D, Neal KR, et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003;125:1651-9.
33. V mice. Am J Physiol Gastrointest Liver Physiol 2001;280:G640-8.
34. Quist RG, Ton-Nu H-T, Lillienau J, et al. Activation of mast cells by bile acids. Gastroenterology 1991;101:446-56.
35. Karlstrom L. Evidence of involvement of the enteric nervous system in the effects of sodium deoxycholate on small-intestinal transepithelial fluid transport and motility. Scand J Gastroenterol 1986;21:321-30.
36. Perdue MH, McKay DM. Integrative immunophysiology in the intestinal mucosa. Am J Physiol 1994;267:G151-65.
37. Stead RH, Kosecka-Janiszewska U, Oestreicher AB, et al. Remodeling of B-50 (GAP-43) & NSE-immunoreactive mucosal nerves in the intestines of rats infected with Nippostrongylus brasiliensis. J Neurosci 1991;11:3809-21.